This case represents the most severe end-stage manifestation of hemophilic elbow arthropathy, with near-maximal structural damage and complete functional disability. The extensive destruction reflects seven decades of inadequate hemostatic control during an era without modern factor replacement therapy. Current management is entirely palliative as structural damage is irreversible. Maximal prophylaxis (FVIII 2500 IU three times weekly) primarily prevents new bleeding rather than improving function. Pain management requires multimodal approach including high-dose opioids (fentanyl patch 75mcg/72h, oxycodone 30mg four times daily), gabapentin 800mg three times daily, and topical therapies, though control remains inadequate. Surgical options are severely limited by age, multiple comorbidities (cirrhosis, HIV, CKD stage 4), poor bone quality, and uncertain benefit given complete ankylosis. Elbow arthrodesis has been discussed but offers minimal functional gain given fixed position already present. Total elbow arthroplasty is contraindicated due to severe bone loss and infection risk. Conservative management focuses on maintaining current state and preventing complications. Physical therapy is limited to pain modulation, positioning for comfort, and preventing skin breakdown. Occupational therapy provides adaptive equipment for activities of daily living performed by caregivers. Psychosocial support addresses severe depression and existential distress related to pain and disability. Quality of life is severely compromised with focus on palliative care principles. This case exemplifies the devastating consequences of hemophilia in the pre-prophylaxis era and underscores the transformative impact of modern comprehensive care in preventing such outcomes.

This case represents moderate hemophilic arthropathy in an elderly patient with acquired hemophilia, complicated by pre-existing age-related joint changes. The combination of hemophilic erosions and age-related osteoarthritic features creates a complex clinical picture. Management is complicated by multiple comorbidities requiring careful medication selection. Current treatment includes prednisone taper, rituximab infusions for inhibitor eradication (current titer reduced to 6 BU), and recombinant activated factor VII for breakthrough bleeding. Joint preservation is prioritized given limited surgical options at this age. Physical therapy adapted for elderly patient focuses on maintaining functional independence: gentle range of motion exercises, adaptive equipment training, and fall prevention strategies. Pain management includes scheduled acetaminophen and topical lidocaine patches (avoiding NSAIDs due to bleeding risk and renal function). Occupational therapy addresses activities of daily living with adaptive devices for dressing, feeding, and grooming. Quality of life considerations are paramount with multidisciplinary team coordination. Follow-up ultrasound planned in 4-6 months to assess progression. Prognosis is guarded with goals focused on maintaining current function and preventing further deterioration rather than improvement. This case highlights challenges of managing acquired hemophilia in elderly patients where treatment goals must balance bleeding control against age-related limitations and comorbidities.